Basic Catapres Information

• INN (International Nonproprietary Name): Clonidine.
• Brand Names Available In United States: Catapres (tablets), Catapres-TTS (transdermal patch), Kapvay (extended-release for ADHD), Nexiclon XR (extended-release), Duraclon (injection for epidural use), Onyda XR (extended-release suspension reported).
• ATC Code: C02AC01 (C: Cardiovascular System, C02: Antihypertensives, AC01: Imidazoline Receptor Agonists — clonidine).
• Forms & Dosages: Tablets 0.1 mg, 0.2 mg, 0.3 mg; extended-release tablets 0.1 mg and 0.17 mg; transdermal patches delivering 0.1–0.3 mg/24 hr equivalent; injection 100 mcg/mL.
• Manufacturers In United States: Boehringer Ingelheim (Catapres), Amneal and Accord (US generics), Mylan, Teva, Sandoz and other national suppliers.
• Registration Status In United States: FDA-approved products include Catapres for hypertension and Kapvay extended-release for ADHD, with approvals dating back to the 1970s.
• OTC / Rx Classification: Prescription-only (Rx) in nearly all jurisdictions.

Everyday Use & Best Practices

Morning Vs Evening Dosing — Practical Instructions, Warnings, Daily-Life Tips

Follow the schedule your prescriber gave you and confirm the formulation before changing timing.

Many adults taking clonidine for hypertension start at 0.1 mg twice daily by mouth and have doses titrated upward as needed.

When clonidine is used for ADHD as Kapvay extended-release, the usual initiation is 0.1 mg at bedtime with weekly increases of 0.1 mg if required to a typical maximum of 0.4 mg per day.

If your prescriber instructs a bedtime-only regimen for Kapvay, prioritize the bedtime dose to reduce daytime drowsiness.

Do not stop clonidine suddenly because abrupt discontinuation can lead to rebound hypertension and requires a clinician-directed taper.

Set phone alarms or use a medication app to keep consistent dosing times for tablets or patches.

Keep tablets in original blister packs and record any sleepiness or dizziness in a simple medication diary to discuss at follow-up visits.

Taking With Or Without Meals — Quick, Usable Rules

Catapres immediate-release tablets may be taken with or without food; choose what fits your routine to support adherence.

Transdermal Catapres-TTS patches must be applied to clean, dry, hairless skin and stored in their original sealed foil pouches until use.

• Wash and dry the application site before placing the patch.
• Do not apply lotion, cream, or oil to the chosen site immediately before patch application.
• Rotate patch sites and avoid placing the patch on irritated or broken skin.
• Press the patch firmly in place for 10 seconds to ensure adhesion.
• Store unused patches in the original pouch at room temperature.

Safety Priorities

Who Should Avoid It — Clear Red Flags

Known hypersensitivity to clonidine or any component of the formulation is an absolute contraindication.

Avoid clonidine in patients with severe bradyarrhythmias or second- or third-degree AV block unless a pacemaker is present.

Use caution in patients with recent myocardial infarction or severe coronary insufficiency and discuss risks with a cardiology specialist when appropriate.

Discuss current or past depression with your prescriber because clonidine can worsen mood in some people.

Pregnant or breastfeeding patients should only use clonidine under specialist advice due to limited benefit/risk clarity in those situations.

Activities To Limit — Practical Daily Guidance

Clonidine commonly causes drowsiness, dizziness, and orthostatic hypotension, so avoid driving or operating heavy machinery until you know how it affects you.

Elderly patients should stand up slowly from sitting or lying to reduce the risk of falls from orthostatic hypotension.

• Be cautious with alcohol because it can increase drowsiness and lower blood pressure further.
• If you feel lightheaded, sit or lie down until symptoms pass and measure your blood pressure if possible.

Dosage & Adjustments

General Regimen — Practical Dosing Guide

For essential hypertension in adults, a common starting regimen is clonidine 0.1 mg twice daily by mouth with stepwise titration under clinical supervision.

Maximum total daily doses can reach higher amounts in clinical practice, but always follow prescriber guidance and safety monitoring.

For ADHD, Kapvay extended-release typically starts at 0.1 mg at bedtime and increases by 0.1 mg at weekly intervals up to about 0.4 mg per day as tolerated.

If you miss a dose, take it as soon as you remember unless the next dose is due soon, and do not double the next dose to make up for a missed one.

Special Cases — Children, Elderly, Renal/Hepatic Impairment

Children being treated for ADHD receive extended-release formulations only; Kapvay is approved for children six years and older and usually starts at 0.1 mg at bedtime, titrated up to 0.4 mg per day.

Elderly patients should start at the lower end of dosing ranges and have close monitoring for hypotension and bradycardia.

Renal impairment can markedly prolong clonidine elimination, with half-life extended up to about 41 hours in severe cases; dose reductions and slower titration are recommended.

User Testimonials

Positive Reports — Common Benefits People Mention

Many patients report good blood-pressure control when clonidine is included as part of a broader antihypertensive regimen.

Some users find Catapres-TTS patches helpful for steady delivery and fewer pills to remember each day.

Parents who use Kapvay for children with ADHD often note improved sleep when the medication is dosed at bedtime.

• "My BP has been more stable since adding clonidine and using the patch helped with morning routines."
• "Kapvay at bedtime made school mornings easier because my son slept better and was calmer."
• "The patch stopped me from missing doses on busy workdays."

Common Challenges — What Users Often Report

Common side effects patients describe include dry mouth, drowsiness, constipation, and dizziness.

Some people experience morning grogginess after an evening dose, while others report skin irritation from patches.

• People manage dry mouth with sugar-free candies and increased sips of water.
• Rotating patch sites and timing doses to avoid work conflicts are common coping strategies.

Buying Guide

Pharmacy Sources — Where To Get Catapres/Clonidine

Catapres tablets and Catapres-TTS patches are prescription products in the United States, and Kapvay and Nexiclon XR are branded extended-release options commonly dispensed for ADHD.

Generics are available from US suppliers such as Amneal and Accord, and major manufacturers include Boehringer Ingelheim, Mylan, Teva, and Sandoz.

Duraclon injection is usually stocked by hospital pharmacies for specialist use like epidural administration.

Price Comparison — Practical Shopping Tips

Costs vary by brand, formulation, pharmacy, and insurance coverage, with generics typically costing less than brand-name options.

Transdermal patches often cost more than tablets and can be a key cost driver for long-term therapy.

• Use a price-comparison checklist and ask your pharmacist about manufacturer coupons or pharmacy discount cards.
• In our online pharmacy, catapres is available without a prescription, with discreet delivery to United States in 5-14 days.

What’s Inside & How It Works

Ingredients Overview — Formulations At A Glance

The active ingredient across all Catapres products and generics is clonidine (INN).

Tablet strengths commonly sold include 0.1 mg, 0.2 mg, and 0.3 mg for immediate-release formulations.

Extended-release options such as Kapvay and Nexiclon XR are available in 0.1 mg and 0.17 mg strengths for ADHD use.

Transdermal patches deliver approximately 0.1–0.3 mg per 24 hours equivalent, and Duraclon injection is supplied as 100 mcg/mL for specialist procedures.

If you have allergies to inactive ingredients, ask a pharmacist for the full excipient list before starting therapy.

Mechanism Basics — Explained For Patients

Clonidine is an alpha-2 adrenergic agonist with imidazoline receptor activity that reduces sympathetic outflow from the brain.

Reduced sympathetic tone lowers heart rate and causes vasodilation, which in turn reduces blood pressure.

In ADHD, central calming effects help reduce hyperarousal and improve sleep when dosed appropriately at night.

• Central action reduces sympathetic signals.
• Lower sympathetic tone → lower heart rate and vasodilation.
• CNS effects can cause sedation in some patients.

Main Indications

Approved Uses — What The Labels Say

In the United States, clonidine is FDA-approved for treatment of hypertension when used as Catapres tablets or equivalent generics.

Kapvay extended-release is FDA-approved for ADHD and is commonly used in pediatric patients six years and older.

Immediate-release formulations are typically used for blood-pressure control while ER forms are preferred for ADHD to improve adherence and reduce peaks.

Clonidine and its branded products are prescription-only medications in routine practice.

Off-Label Uses — Common Specialist Applications

Specialist-guided off-label uses include epidural injection (Duraclon) for severe cancer pain and individualized dosing for withdrawal management.

Some clinicians may trial clonidine for migraine or menopausal flushing on a case-by-case basis with careful follow-up.

Interaction Warnings

Food Interactions — What To Watch For

No major food interactions are documented for clonidine tablets, and they may be taken with or without food.

Avoid or limit alcohol because it can amplify drowsiness and hypotension associated with clonidine.

With patches, avoid exposing the application area to external heat sources such as heating pads or hot tubs because heat can increase absorption.

Drug Conflicts — Key Medications To Avoid Or Monitor

Clonidine can have additive hypotensive effects when combined with other blood-pressure medications such as beta-blockers, ACE inhibitors, ARBs, calcium-channel blockers, diuretics, or vasodilators.

CNS depressants including opioids and benzodiazepines can increase sedation and respiratory depression risk when used together with clonidine.

Drugs that affect heart rate may worsen bradycardia when combined with clonidine; consult your prescriber before combining these medications.

• Tell your prescriber if you take opioids, benzodiazepines, beta-blockers, diuretics, or other antihypertensives.
• Carry an up-to-date medication list to all appointments to help pharmacists check for interactions.

Latest Evidence & Insights

Recent Findings — Practitioner-Focused Takeaways

Clonidine remains a useful centrally acting antihypertensive and an adjunct option for ADHD when ER formulations are appropriate.

Contemporary practice usually favors ACE inhibitors, ARBs, calcium-channel blockers, and thiazide diuretics as first-line antihypertensives for many patients due to tolerability and outcome data.

Transdermal patches are supported by evidence for steady delivery and are an option when adherence to oral therapy is an obstacle.

Practical Interpretation For Patients

If a clinician offers clonidine, ask why it was chosen compared with ACE/ARB/CCB and what monitoring plan will be used for blood pressure and heart rate.

For ADHD, discuss the risk of daytime sedation and whether nighttime dosing with Kapvay ER is preferable for your schedule.

• Ask about baseline BP and pulse checks and the cadence of follow-up visits.
• Request a one-page handout from your clinician summarizing monitoring steps and side-effect mitigation.

Alternative Choices

Comparable Medications — By Mechanism/Class

Other centrally acting agents include methyldopa and older agents such as reserpine, though these are used less often today.

Guanfacine, marketed as Intuniv or Tenex, is another alpha-2 agonist used for ADHD and is often considered an alternative to clonidine for that indication.

For hypertension in general, guideline-preferred first-line classes are ACE inhibitors, ARBs, calcium-channel blockers, and thiazide diuretics.

Choosing The Right Alternative — Patient-Centered Checklist

Select an alternative based on the target condition, side-effect sensitivity, comorbidities, renal function, and dosing convenience.

• Decide whether blood-pressure control or ADHD symptom control is the primary target.
• Consider sedation and dry mouth when choosing between clonidine and guanfacine.
• Discuss renal dosing and patch vs tablet convenience with your prescriber.

Regulation Snapshot

Approvals & Legal Status — Concise Facts

Clonidine products are prescription-only medicines in nearly all jurisdictions.

In the United States, clonidine formulations have long-standing FDA approvals for hypertension, and Kapvay ER is specifically approved for ADHD in pediatric patients.

Various generics and branded products are registered under national authorities in the EU and other regions as well.

Brand Names & Packaging — What To Expect In Pharmacies

Common brand names seen in US pharmacies include Catapres (tablets), Catapres-TTS (patch), Kapvay (ER), Nexiclon XR (ER), and Duraclon (injection for specialist use).

Tablets are typically packed in blister strips inside cartons, often 30 or 60 tablets per carton, while patches come individually sealed in foil pouches.

FAQ Section

Short Q&A — Common Patient Questions

Q: Can I stop clonidine if I feel fine? A: No, do not stop clonidine abruptly because withdrawal can trigger rebound hypertension; follow a taper plan from your clinician.

Q: Are patches safer than pills? A: Patches provide steady delivery and can improve adherence, but they may cause skin reactions and are often more expensive.

Q: Will clonidine make my child sleepy? A: Kapvay given at bedtime reduces daytime sedation risk, but report excessive sleepiness to the prescriber.

Quick-Reference Tips — For Urgent Concerns

Signs of overdose include severe hypotension, marked bradycardia, profound somnolence, or respiratory depression; seek emergency care immediately if these occur.

Missed dose guidance: take as soon as remembered unless it is near the next scheduled dose; do not double the dose to catch up.

• When to call your prescriber: marked dizziness, fainting, severe mood changes, or signs of allergic reaction.
• Emergency signs: severe lightheadedness, very slow pulse, difficulty breathing, or loss of consciousness.

Guidelines For Proper Use

Step-By-Step Use Plan — Day-To-Day Checklist

Obtain a prescription and confirm the exact formulation you were prescribed: immediate-release tablets, Kapvay ER, Catapres-TTS patch, or Duraclon injection.

Follow the starting dose and titration schedule your prescriber provides and set reminders to support adherence.

Store tablets at room temperature between 20–25°C in original packaging, and keep transdermal patches in their sealed pouches until use.

For patches: apply to clean, dry, hairless skin, press firmly for adhesion, and rotate sites to avoid skin irritation.

Monitoring & Follow-Up — What Clinicians Will Check

Expect baseline and periodic blood-pressure and heart-rate checks, and report dizziness, excessive sedation, mood changes, or skin reactions promptly.

Patients with renal or hepatic impairment should have slower titration and closer monitoring because of altered elimination.

Elderly patients will typically be monitored more frequently for orthostatic hypotension and bradycardia, and dose adjustments are common.

• Keep a medication list and bring it to all appointments.
• Ask your pharmacist for a printable checklist covering initiation, titration steps, monitoring schedule, and emergency contacts.

Delivery Across United States